Severe disease and mortality related to Omricon are significantly reduced
- Why Botulinum Toxin Reigns as One of the Deadliest Poisons?
- FDA Approves Pfizer’s One-Time Gene Therapy for Hemophilia B: $3.5 Million per Dose
- Aspirin: Study Finds Greater Benefits for These Colorectal Cancer Patients
- Cancer Can Occur Without Genetic Mutations?
- Statins Lower Blood Lipids: How Long is a Course?
- Warning: Smartwatch Blood Sugar Measurement Deemed Dangerous
Severe disease and mortality related to Omricon are significantly reduced
- Red Yeast Rice Scare Grips Japan: Over 114 Hospitalized and 5 Deaths
- Long COVID Brain Fog: Blood-Brain Barrier Damage and Persistent Inflammation
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Severe disease and mortality related to Omricon are significantly reduced.
Large-scale study shows that the severe disease and mortality related to Omicron are significantly reduced compared to Delta.
Recently, researchers at the University of California, Berkeley , Kaiser Permanente Hospital in Southern California, and the U.S. Centers for Disease Control and Prevention published a preprint paper analyzing about 52,000 people infected with the Omicron mutant and about 17,000 people infected with the Delta mutant.
People infected with Omicron were 50% less likely to be hospitalized, 75% less likely to be admitted to the ICU, and 91% less likely to die, compared to those infected with Delta .
The median length of hospital stay for people with Omicron was 1.5 days, compared to a Delta of 5 days, and 90% of people with Omicron were discharged in 3 days or less .
None of the 52,000 people infected with the Omicron mutant ended up on a ventilator , compared with 11 of the 17,000 people infected with the Delta mutant .
The analyses were based on data from the Kaiser Permanente hospital system in Southern California , which served approximately 4.7 million people with COVID-19-related services between November 30, 2021, and January 1, 2022, during which time Delta and Omicron Pretty popular in the US.
Rochelle Walensky , director of the CDC, said the study controlled for important key parameters such as age, gender, prior journals of Covid-19 infection, vaccinations and comorbidities .
The results of this study show that Omicron is inherently less severe than Delta .
Although the study also showed that the vaccine was less effective in preventing Omicron infection, the vaccine still protected her from severe disease.
Rochelle Walensky also cautioned that while the study showed a dramatic drop in the risk of hospitalization, severe illness and death after Omicron infection, it should not let down our guard now, because Omicron is so contagious that the current U.S. health care system and health care workers overwhelmed.
About 1 million people are infected every day in the United States, most of them Omicron, 150,000 people are hospitalized with COVID-19s every day, and more than 1,600 people die every day from it.
Anthony Fauci, President Biden’s chief medical adviser , said: ” Omicron, with its powerful and unprecedented transmission efficiency, will eventually infect almost everyone [ in the United States] .
He also said that when the United States emerges from the current wave of infections, it will transition to a state of coexistence with the new coronavirus in the future, and the COVID-19 vaccine can help most people avoid developing severe disease and provide effective treatment for those most vulnerable.
Severe disease and mortality related to Omricon are significantly reduced
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.
